Marker Therapeutics, Inc. — Director's Dealing 2020

Jun 19, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Marker Therapeutics, Inc. (MRKR)
CIK: 0001094038
Period of Report: 2020-06-16

Reporting Person: Eastern Capital LTD (10% Owner)
Reporting Person: Portfolio Services Ltd. (10% Owner)
Reporting Person: DART KENNETH BRYAN (10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-16	Series E-1 Warrant	$15	J	416667	Disposed	2020-06-16	Common Stock (0)	Direct

Footnotes

F1: The Series E-1 Warrant to purchase 416,667 shares of Common Stock of the Issuer at the exercise price of $15.00 per share with an expiration date of June 16, 2020, was not exercised by the Reporting Persons before such expiration.